Donia Qayed

Safety and Immunogenicity of COVID-19 BBIBP-CorV Vaccine in Children 3–12 Years Old

A. Alsayyad, K. Greish, A. Alawadhi, 2022, Vaccines.

Safety and efficacy of COVID-19 prime-boost vaccinations: Homologous BBIBP-CorV versus heterologous BNT162b2 boosters in BBIBP-CorV-primed individuals

S. Atkin, A. Mubarak, A. Butler, 2023, Vaccine.